Search Clinical Trials
Thank you for your interest in research at UTMB! Taking part in research is one way to be part of tomorrow’s healthcare discoveries. UTMB is always looking for volunteers just like you so that our researchers can better understand how to prevent, diagnose, and treat diseases. Everyone is needed. Both healthy volunteers and people with health conditions can help us answer important questions that impact the health of our communities. Ready to start searching for a study to be involved with?
- Enter a health condition or leave it blank if you are looking to join any study as a healthy volunteer
- Enter your gender and age
- Click “View Results”
- Click on the study titles for information
- Click on the “Contact/Details” tab to get information for contacting the study team
| Sponsor Condition of Interest |
|---|
|
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoace1
Innoviva Specialty Therapeutics
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam
(SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK)
and safety data to enable the identification of appropriate pediatric dosing regimens for
patients with Acinetobacter baumannii-c1 expand
The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections Type: Interventional Start Date: Oct 2026 |
|
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary I1
Calliditas Therapeutics AB
IgA Nephropathy
The goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO®
(delayed-release budesonide capsules) treatment in adult patients with primary IgA
nephropathy who have completed 9 months of TARPEYO® 16 mg once daily treatment in
real-world clinical practice. The main quest1 expand
The goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO® (delayed-release budesonide capsules) treatment in adult patients with primary IgA nephropathy who have completed 9 months of TARPEYO® 16 mg once daily treatment in real-world clinical practice. The main question it aims to answer is: Is there a treatment benefit of TARPEYO® 16 mg QD extended use? Participants will - take part in this study for about 19 months - Have urine tests done - Have blood samples taken - Have physical examinations done Type: Interventional Start Date: Dec 2024 |
|
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
The University of Texas Medical Branch, Galveston
Subarachnoid Hemorrhage, Aneurysmal
Headache
Opiate Dependence
Opioid Use
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without
steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in
patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of
this treatment. expand
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment. Type: Interventional Start Date: Jan 2026 |
|
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and1
The University of Texas Medical Branch, Galveston
Brain Injuries
The aim of this study is to characterize the microbiome of patients undergoing post-acute
residential neurorehabilitation compared to community controls and to determine if a
dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue
and cognition. expand
The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition. Type: Interventional Start Date: Mar 2025 |
|
The Gut Microbiome and Immunotherapy Response in Solid Cancers
The University of Texas Medical Branch, Galveston
Cancer
The aim of this study is characterize the gastrointestinal microbiomes of patient with
solid cancer undergoing standard of care treatment with programmed cell death protein 1
(PD-1) /programmed cell death ligand (PD-L1) blockade. expand
The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade. Type: Observational Start Date: Jun 2023 |
|
Wearable Echolocation Aids Using Parametric Sound
The University of Texas Medical Branch, Galveston
Low Vision
The objective of this study is to study a novel device designed to aid patients with
impaired vision to safely navigate their environment. Subjects for this study will be
individuals with normal vision, either with or without correction. The subjects will wear
a device to simulate impaired vision a1 expand
The objective of this study is to study a novel device designed to aid patients with impaired vision to safely navigate their environment. Subjects for this study will be individuals with normal vision, either with or without correction. The subjects will wear a device to simulate impaired vision and will be asked to walk a path with randomly placed obstacles during two trials. One of the trials will consist of the subject wearing the simulator alone. The other trial will consist of the subject wearing the simulator and the study device. The study device is designed to be worn by the study subject and will emit tones to indicate obstacles in the environment as the subject walks on the path with random obstacles. The tones will indicate that there is an obstacle in the individual's path and will increase in intensity as the subject moves closer to the object.Invest Type: Interventional Start Date: Feb 2025 |